Recruiting NA Malnutrition, Infant

Tests treatment safety and results for Malnutrition, Infant

Official title Efficacy of Mobile Health Application in Promotion of Exclusive Breast Feeding and Young Child Feeding Practices in Pakistan

ClinicalTrials.gov ID: NCT05590351

What this study is testing

What it's testing
Early life nutrition is the key modifiable determinant of child growth, development, survival and diseases of adult onset. Pakistan ranks highest for neonatal mortality rate (44.2/1000 live births (LBs)) globally.
  • Time commitment: about 6 months

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 48, women only. Healthy volunteers may be eligible.

You may be able to join if

  • Pregnant women in the third trimester at 36 +/- 1 week of gestation.
  • Planned to stay in their respective areas for at least 1 year after delivery
  • Planned to get the infant immunized from the respective FHC of the hospitals.
  • Have access to smart phones with internet connection.
  • Registered and planning to deliver to any of the Secondary Care Hospitals

You likely can't join if

  • High-risk including maternal neurological/heart/ autoimmune/renal disease, preeclampsia, placenta previa, multiple gestations (twins/triplets), fetal...
  • Women who plan to move to different location after delivery
See the full eligibility criteria
Who can join
  • Pregnant women in the third trimester at 36 +/- 1 week of gestation.
  • Planned to stay in their respective areas for at least 1 year after delivery
  • Planned to get the infant immunized from the respective FHC of the hospitals.
  • Have access to smart phones with internet connection.
  • Registered and planning to deliver to any of the Secondary Care Hospitals
  • Can read and write in local language (English and/or Urdu).
  • Consent to participate and remain in the study until 1 year of child age
What rules you out
  • High-risk including maternal neurological/heart/ autoimmune/renal disease, preeclampsia, placenta previa, multiple gestations (twins/triplets), fetal structural/genetic anomalies, fetal growth restrictions, and birth...
  • Women who plan to move to different location after delivery

The study team makes the final eligibility decision.

Where it's taking place

  • Karachi, Sindh, Pakistan

Compensation & support

Compensation mentioned.

ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The study runs about 6 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.

Who can join this trial?

This study is enrolling female, 18 years to 48 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Karachi, Sindh, Pakistan. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.